Cost-effectiveness Study of miRview™ Mets in Patients With Cancer of Unknown Primary (CUP)

NCT01202786 · clinicaltrials.gov ↗

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Neoplasms, Unknown Primary

Sponsor

Teva Branded Pharmaceutical Products R&D, Inc.

Collaborators

[object Object]
[object Object]